Preeclampsia and androgen receptor gene CAG repeat length: Results from both children and women

Journal of Assisted Reproduction and Genetics

Volumn 22, Issue 7, 2005, Pages 269-275

  Saarela, Tanja ^a   Jääskeläinen, Jarmo ^a   Tenhola, Sirpa ^a   Voutilainen, Raimo ^a   Heinonen, Seppo ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Androgen receptor; CAG; Polymorphism; Preeclampsia; SAG

Indexed keywords

ADENINE NUCLEOTIDE; ANDROGEN RECEPTOR; GLUTAMINE; GUANINE NUCLEOTIDE; PYRIMIDINE NUCLEOTIDE;

ADULT; ARTICLE; BIRTH; BOY; CHILD; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE REPEAT; PREDICTION; PREECLAMPSIA; PREGNANCY; PREGNANCY DISORDER; PRIORITY JOURNAL;

ADULT; BIRTH WEIGHT; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MALE; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, ANDROGEN; RISK FACTORS; TRINUCLEOTIDE REPEATS;

EID: 26244465893     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10815-005-5349-9     Document Type: Article

References (38)

1. Brown CJ, Goss SJ, Lubahn DB, Joseph DR, Wilson EM, French FS, Willard HF: Androgen receptor locus on the human X chromosome: Regional localization to Xq11-12 and description of a DNA polymorphism. Am J Hum Genet 1989;44:264-269
2. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS: Androgen receptor defects: Historical, clinical, and molecular perspectives. Endocr Rev 1995;16:271-321
3. Choong CS, Kemppainen JA, Zhou ZX, Wilson EM: Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol Endocrinol 1996;10:1527-1535
4. Chamberlain NL, Driver ED, Miesfeld RL: The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994;22:3181-3186
5. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH: Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991;52:77-79
6. Balic I, Graham ST, Troyer DA, Higgins BA, Pollock BH, Johnson-Pais TL, Thompson IM, Leach RJ: Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men. J Urol 2002;168:2245-2248
7. Mononen N, Ikonen T, Autio V, Rokman A, Matikainen MP, Tammela TL, Kallioniemi OP, Koivisto PA, Schleutker J: Androgen receptor CAG polymorphism and prostate cancer risk. Hum Genet 2002;111:166-171
8. Giovannucci E, Platz EA, Stampfer MJ, Chan A, Krithivas K, Kawachi I, Willett WC, Kantoff PW: The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia. Urology 1999;53:121-125
9. Roberts RO, Bergstralh EJ, Cunningham JM, Hebbring SJ, Thibodeau SN, Lieber MM, Jacobsen SJ: Androgen receptor gene polymorphisms and increased risk of urologic measures of benign prostatic hyperplasia. Am J Epidemiol 2004;159:269-276
10. Yong EL, Loy CJ, Sim KS: Androgen receptor gene and male infertility. Hum Reprod Update 2003;9:1-7
11. Ochsenkuhn R, De Kretser DM: The contributions of deficient androgen action in spermatogenic disorders. Int J Androl 2003;26:195-201
12. Elhaji YA, Gottlieb B, Lumbroso R, Beitel LK, Foulkes WD, Pinsky L, Trifiro MA: The polymorphic CAG repeat of the androgen receptor gene: A potential role in breast cancer in women over 40. Breast Cancer Res Treat 2001;70:109-116
13. Dagan E, Friedman E, Paperna T, Carmi N, Gershoni-Baruch R: Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: Association with breast/ovarian cancer phenotype. Eur J Hum Genet 2002;10:724-728
14. Chen HY, Chen WC, Wu MC, Tsai FJ, Tsai CH: Androgen receptor (AR) gene microsatellite polymorphism in postmenopausal women: Correlation to bone mineral density and susceptibility to osteoporosis. Eur J Obstet Gynecol Reprod Biol 2003;107:52-56
15. Langdahl BL, Stenkjaer L, Carstens M, Tofteng CL, Eriksen EF: A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures. Calcif Tissue Int 2003;73:237-243
16. Hickey T, Chandy A, Norman RJ: The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:161-165
17. Mifsud A, Ramirez S, Yong EL: Androgen receptor gene CAG trinucleotide repeats in anovulatory infertility and polycystic ovaries. J Clin Endocrinol Metab 2000;85:3484-3488
18. Acromite MT, Mantzoros CS, Leach RE, Hurwitz J, Dorey LG: Androgens in preeclampsia. Am J Obstet Gynecol 1999;180:60-63
19. Serin IS, Kula M, Basbug M, Unluhizarci K, Gucer S, Tayyar M: Androgen levels of preeclamptic patients in the third trimester of pregnancy and six weeks after delivery. Acta Obstet Gynecol Scand 2001;80:1009-1013
20. Laivuori H, Kaaja R, Rutanen EM, Viinikka L, Ylikorkala O: Evidence of high circulating testosterone in women with prior preeclampsia. J Clin Endocrinol Metab 1998;83:344-347
21. Laivuori H, Tikkanen MJ, Ylikorkala O: Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab 1996;81:2908-2911
22. Bachmann J, Feldmer M, Ganten U, Stock G, Ganten D: Sexual dimorphism of blood pressure: possible role of the renin-angiotensin system. J Steroid Biochem Mol Biol 1991;40:511-515
23. Mantzoros CS, Georgiadis EI, Young R, Evagelopoulou C, Khoury S, Katsilambros N, Sowers JR: Relative androgenicity, blood pressure levels, and cardiovascular risk factors in young healthy women. Am J Hypertens 1995;8:606-614
24. Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, Irgens LM: Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ 1998;316:1343-1347
25. Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G, Carrillo J, Varner MW: Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 2001;344:867-872
26. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-S22
27. Chesley LC, Cooper DW: Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women. Br J Obstet Gynaecol 1986;93:898-908
28. Arngrimsson R, Bjornsson S, Geirsson RT, Bjornsson H, Walker JJ, Snaedal G: Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol 1990;97:762-769
29. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ: Weight in infancy and death from ischaemic heart disease. Lancet 1989;2:577-580
30. Hannaford P, Ferry S, Hirsch S: Cardiovascular sequelae of toxaemia of pregnancy. Heart 1997;77:154-158
31. Law CM, Shiell AW: Is blood pressure inversely related to birth weight? The strength of evidence from a systematic review of the literature. J Hypertens 1996;14:935-941
32. Rahiala E, Tenhola S, Vanninen E, Herrgard E, Tikanoja T, Martikainen A: Ambulatory blood pressure in 12-year-old children born small for gestational age. Hypertension 2002;39:909-913
33. Tenhola S, Rahiala E, Martikainen A, Halonen P, Voutilainen R: Blood pressure, serum lipids, fasting insulin, and adrenal hormones in 12-year-old children born with maternal preeclampsia. J Clin Endocrinol Metab 2003;88:1217-1222
34. Innes KE, Marshall JA, Byers TE, Calonge N: A woman's own birth weight and gestational age predict her later risk of developing preeclampsia, a precursor of chronic disease. Epidemiology 1999;10:153-160
35. Veening MA, Van Weissenbruch MM, Delemarre-Van De Waal HA: Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. J Clin Endocrinol Metab 2002;87:4657-4661
36. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, Winter PD: Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991;303:1019-1022
37. Francois I, de Zegher F: Adrenarche and fetal growth. Pediatr Res 1997;41:440-442
38. Tenhola S, Martikainen A, Rahiala E, Parviainen M, Halonen P, Voutilainen R: Increased adrenocortical and adrenomedullary hormonal activity in 12-year-old children born small for gestational age. J Pediatr 2002;141:477-482